Paid Clinical Trials in Memphis, TN

As of September 2026, 452 paid clinical trials are recruiting in Memphis, Tennessee. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Memphis offers studies at sites including St. Jude Children's Research Hospital for conditions such as Sickle Cell Disease, Acute Myeloid Leukemia, Neuroblastoma, Acute Lymphoblastic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Trials by specialty in Memphis

Oncology· 197 Blood cancer· 70 Pediatric oncology· 32 Lung oncology· 21 Neurology· 20 Cardiology· 19 Heart disease· 18 Brain disorders· 18 GI oncology· 16 Behavioral health· 15 Women's health· 15 Endocrinology· 14

Trials by drug in Memphis

Methotrexate· 8 Dexamethasone· 7 Interview· 5 Folinic acid· 4 Semaglutide· 4 Anastrozole· 2 Bupropion· 2 Letrozole· 2 Mammography· 2 Palbociclib· 2 Prednisone· 2 SoC· 2 Vehicle· 2 Amitriptyline· 1

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Memphis

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

A Registry of Cases of Spinal Muscular Atrophy

for Spinal Muscular Atrophy

1 location in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: All ages

Code: NCT07805278·Recruiting·Listed Sep 4, 2026

Apply to this trial

Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

for Smoking Cessation

Sites in Memphis, Knoxville +14 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 65

Code: NCT07766655·Phase 3·Recruiting·Listed Aug 14, 2026

Apply to this trial

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

for Type 2 Diabetes

Drug: Survodutide

Sites in Memphis, Chattanooga +87 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07754461·Phase 3·Recruiting·Listed Aug 10, 2026

Apply to this trial

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

for Obesity

Sites in Memphis +84 more locations

Sponsor: Ascletis Pharma (China) Co., Limited

Sex: All·Age: 18+

Code: NCT07743450·Phase 3·Recruiting·Listed Aug 3, 2026

Apply to this trial

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

for Obesity

Sites in Memphis +66 more locations

Sponsor: Ascletis Pharma (China) Co., Limited

Sex: All·Age: 18+

Code: NCT07743463·Phase 3·Recruiting·Listed Aug 3, 2026

Apply to this trial

Screen2Prevent (S2P)

for HIV Infections

Sites in Memphis +4 more locations

Sponsor: Westat

Sex: All·Age: 14 - 24·Accepts healthy volunteers

Code: NCT07728123·Recruiting·Listed Jul 27, 2026

Apply to this trial

405 clinical trials

Get a weekly email when new trials open in Memphis, TN.

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

for Diabetes Mellitus, Type 2

Sites in Memphis +24 more locations

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18 - 75

Code: NCT07668388·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for Pneumococcal Disease

Sites in Memphis, Tullahoma +104 more locations

Sponsor: Pfizer

Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers

Code: NCT07629440·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

for Systemic Lupus Erythematosus

Drug: BI 3000202

Sites in Memphis, Jackson +28 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18 - 74

Code: NCT07409181·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for Adenovirus Infections

Sites in Memphis +31 more locations

Sponsor: SymBio Pharmaceuticals

Sex: All·Age: 2 Months+

Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

for Chronic Idiopathic Constipation (CIC)

Drug: Tenapanor

Sites in Memphis, Nashville +107 more locations

Sponsor: Ardelyx

Sex: All·Age: 18 - 80

Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for Clostridoides Difficile Associated Disease

Sites in Memphis, Nashville +138 more locations

Sponsor: Pfizer

Sex: All·Age: 65+·Accepts healthy volunteers

Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for Diabetic Peripheral Neuropathic Pain

Sites in Memphis, Chattanooga +68 more locations

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All·Age: 18 - 80

Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

Sites in Memphis, Germantown +221 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

for Overweight

Sites in Memphis +33 more locations

Sponsor: Novo Nordisk A/S

Sex: All·Age: 8 - 18

Code: NCT07253285·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Buntanetap in Participants With PD

for Parkinson's Disease (PD)

Sites in Memphis, Cordova +25 more locations

Sponsor: Annovis Bio Inc.

Sex: All·Age: 40 - 85

Code: NCT07284784·Phase 2, Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for Major Depressive Disorder

Drug: Icalcaprant

Sites in Memphis +32 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT07276997·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

for Obesity With Diabetes

Sites in Memphis +58 more locations

Sponsor: Kailera

Sex: All·Age: 18+

Code: NCT07284901·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for Dystonia

Sites in Memphis, Nashville +35 more locations

Sponsor: Vima Therapeutics

Sex: All·Age: 18 - 65

Code: NCT07304089·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease

for Proteinuric Kidney Disease

Sites in Memphis, Nashville +137 more locations

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All·Age: 10 - 65

Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in Memphis, Nashville +170 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for Bipolar Disorder

Sites in Memphis +32 more locations

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07172516·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for End Stage Kidney Disease

Drug: Clazakizumab

Sites in Memphis, Nashville +146 more locations

Sponsor: CSL Behring

Sex: All·Age: 18+

Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022

Apply to this trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for Triple-Negative Breast Cancer

Sites in Memphis, Germantown +81 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06393374·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Memphis, Nashville +86 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for Parkinson's Disease

Drug: Prasinezumab

Sites in Memphis, Nashville +51 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 50 - 85

Code: NCT07174310·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

for Lumbar Spinal Stenosis

Sites in Memphis, Cordova +2386 more locations

Sponsor: Stryker Instruments

Sex: All·Age: 18+

Code: NCT03072927·Recruiting·Listed Mar 2017

Apply to this trial

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for Non-Small Cell Lung Cancer

Drug: Divarasib

Sites in Memphis +59 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

for Attention-Deficit/Hyperactivity Disorder

Sites in Memphis +46 more locations

Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All·Age: 48 Months - 69 Months

Code: NCT04781140·Phase 4·Recruiting·Listed Mar 2021

Apply to this trial

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for Acute Myeloid Leukemia (AML)

Sites in Memphis, Nashville +40 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

for Non-small Cell Lung Cancer

Drug: Intismeran autogene

Sites in Memphis, Nashville +56 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06077760·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

for Geographic Atrophy

Sites in Memphis, Nashville +53 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: All ages

Code: NCT06779773·Recruiting·Listed Jan 2025

Apply to this trial

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for Metastatic Breast Cancer

Drug: Zongertinib

Sites in Memphis, Nashville +24 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06324357·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for Prostate Cancer

Sites in Memphis, Nashville +48 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Male·Age: 18+

Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

for Cardiovascular Diseases

Sites in Memphis +46 more locations

Sponsor: BrioHealth Solutions, Inc.

Sex: All·Age: 18 - 100

Code: NCT06310031·Recruiting·Listed Mar 2024

Apply to this trial

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

for Kidney Disease, Chronic

Drug: Empagliflozin

Sites in Memphis +48 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06531824·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Strategy for Improving Stroke Treatment Response

for Ischemic Stroke

Sites in Memphis +39 more locations

Sponsor: Translational Sciences, Inc.

Sex: All·Age: 18+

Code: NCT05948566·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Etentamig

Sites in Memphis, Nashville +25 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05650632·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for Colorectal Cancer

Sites in Memphis, Nashville +30 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06562543·Phase 4·Recruiting·Listed Aug 2024

Apply to this trial

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Sites in Memphis +22 more locations

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020

Apply to this trial

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for Sickle Cell Disease

Drug: Etavopivat

Sites in Memphis +43 more locations

Sponsor: Novo Nordisk A/S

Sex: All·Age: 12+

Code: NCT06612268·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

for Type 1 Diabetes Mellitus

Sites in Memphis, Chattanooga +43 more locations

Sponsor: COUR Pharmaceutical Development Company, Inc.

Sex: All·Age: 12 - 35

Code: NCT06783309·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for Chronic Graft-versus-host-disease

Sites in Memphis +35 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 12+

Code: NCT06585774·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

for Cancer Weight Loss

Sites in Memphis, Nashville +23 more locations

Sponsor: Endevica Bio

Sex: All·Age: 18+

Code: NCT06937177·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for Non-muscle Invasive Bladder Cancer

Sites in Memphis, Nashville +34 more locations

Sponsor: Protara Therapeutics

Sex: All·Age: 18+

Code: NCT05951179·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for Non-Small Cell Lung Cancer, NSCLC

Sites in Memphis, Nashville +26 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06162221·Phase 1, Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Top Research Study Locations in Memphis

Researchers run research studies in Memphis, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
St. Jude Children's Research Hospital	Sickle Cell Disease, Hematologic Malignancy, Pediatric Cancer	126
Baptist Memorial Hospital and Cancer Center-Memphis	Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia	49
Saint Jude Children's Research Hospital	Malignant Solid Neoplasm, Neuroblastoma, Acute Myeloid Leukemia Post Cytotoxic Therapy	27
Le Bonheur Children's Hospital	Congenital Heart Disease (CHD), Alagille Syndrome, Anti-myostatin	21
Baptist Cancer Center	Non-Small Cell Lung Cancer, Breast Cancer, Chronic Graft-versus-host-disease	11
Baptist Clinical Research Institute	Non-small Cell Lung Cancer, Acute Myeloid Leukemia (AML), Acute Myocardial Infarction	9
University of Tennessee Health Science Center	Aneurysm, Brain, Buccal Mucosa Squamous Cell Carcinoma, Cancer	9
Regional One Health	Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Burn, Cesarean Delivery	8
LeBonheur Children's Hospital	Anesthesia, Children, Congenital Abnormalities	6
Southern College of Optometry	Amblyopia, Choroid, Myopia	5
Baptist Memorial Hospital	Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder	5
Clinical Neuroscience Solutions, LLC	Bipolar Depression, Bipolar Disorder, Bipolar I Disorder	4
Memphis VA Medical Center, Memphis, TN	Atherosclerosis, Chronic Kidney Disease (CKD) Stage 5, Dialysis Dependency	4
St Jude Children's Research Hospital	AML/MDS, Anesthesia, B-ALL	4
The Southern College of Optometry	Dry Eye, Presbyopia, Contact Lens Comfort	4
Baptist Memorial Hospital for Women	Breast Carcinoma, Cancer, Colorectal Carcinoma	3
Clinical Neuroscience Solutions, Inc.	Attention-Deficit/Hyperactivity Disorder, Major Depressive Disorder, OSA	3
LifeDoc Health	Diabetes Mellitus, Type 2, Obesity, Overweight	3
Methodist Le Bonheur Healthcare	Coronary Artery Disease, Spinal Muscular Atrophy (SMA)	3
Methodist University Hospital	Intracerebral Hemorrhage, Ischemic Stroke, Atrial Fibrillation	3
Semmes Murphey Clinic	ICAD - Intracranial Atherosclerotic Disease, Intracranial Aneurysms, Ischemic Stroke	3
Shelby Research LLC	Systemic Lupus Erythematosus, Sjögren´s Disease	3
Baptist Cancer Center - Memphis	Colorectal Cancer, Esophageal Adenocarcinoma, Extensive-stage Small Cell Lung Cancer (ES-SCLC)	2
CNS Healthcare - Memphis	Diabetic Peripheral Neuropathic Pain, Obstructive Sleep Apnea (OSA)	2
Lt. Col. Luke Weathers, Jr. VA Medical Center	Acute Kidney Injury (AKI), Continuous Renal Replacement Therapy (CRRT), End Stage Kidney Disease	2

Active & Upcoming Studies in Memphis (2026)

Recruiting trials in Memphis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in Memphis

Sickle Cell Disease (18 active studies)
Cancer (12 active studies)
Acute Myeloid Leukemia (9 active studies)
Neuroblastoma (8 active studies)
Acute Lymphoblastic Leukemia (6 active studies)
Hematologic Malignancy (6 active studies)

Leading research sponsors in Memphis

St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Children's Oncology Group
SWOG Cancer Research Network
University of Tennessee

Frequently asked questions

How many paid clinical trials are currently recruiting in Memphis?

There are approximately 452 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Memphis pay participants?

Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Memphis?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Memphis?

The most common conditions under active study in Memphis include Sickle Cell Disease (18), Cancer (12), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Memphis?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Memphis?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Memphis?

Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Memphis right now?

The largest active categories in Memphis are Cancer & tumors (166), Cardiovascular (25), Neurology & pain (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Related healthcare resources in Tennessee

Latest Tennessee clinical trials research report

Trials by condition in Memphis

Sickle Cell Disease· 18 Acute Myeloid Leukemia· 9 Neuroblastoma· 8 Hodgkin Lymphoma· 6

Paid Clinical Trials in Memphis, TN

Trials by specialty in Memphis

Trials by drug in Memphis

Newly added in Memphis

405 clinical trials

Top Research Study Locations in Memphis

Active & Upcoming Studies in Memphis (2026)

Cancer & tumors (166 active studies)

Cardiovascular (25 active studies)

Neurology & pain (22 active studies)

Diabetes & metabolic (18 active studies)

Pediatric (16 active studies)

HIV / STI (11 active studies)

Mental health & behavior (7 active studies)

Eye & vision (7 active studies)

Vaccines (1 active study)

Common conditions studied in Memphis

Leading research sponsors in Memphis

Frequently asked questions

How many paid clinical trials are currently recruiting in Memphis?

Do clinical trials in Memphis pay participants?

Who can participate in a clinical trial in Memphis?

What conditions are most commonly studied in Memphis?

Are there clinical trials for healthy volunteers in Memphis?

How do I enroll in a clinical trial in Memphis?

Where can I take part in paid clinical trials in Memphis?

What kinds of studies are recruiting in Memphis right now?

Browse more clinical trials

Other cities in Tennessee

Related healthcare resources in Tennessee

Trials by condition in Memphis